The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126692271 12669227 1 I 20160809 20160819 20160819 EXP TR-BAYER-2016-155030 BAYER YILMAZ S; OZCAKAR ZB; YALCINKAYA F; TAKTAK A; KIREMITCI S; ENSARI A; DINCASLAN H. ANTI-VEGF-RELATED THROMBOTIC MICROANGIOPATHY IN A CHILD PRESENTING WITH NEPHROTIC SYNDROME. PEDIATRIC NEPHROLOGY,. 2016;31 (6),:1029-1032, 15.00 YR T M Y 0.00000 20160819 OT TR TR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126692271 12669227 1 PS SORAFENIB (RAF KINASE INHIBITOR) SORAFENIB 1 400 MG, QD 21923 400 MG FILM-COATED TABLET QD
126692271 12669227 2 SS BEVACIZUMAB BEVACIZUMAB 1 400 MG, Q2WK 0 400 MG QOW
126692271 12669227 3 C ADRIAMYCIN DOXORUBICIN HYDROCHLORIDE 1 0
126692271 12669227 4 C CISPLATIN. CISPLATIN 1 0
126692271 12669227 5 C METHOTREXATE. METHOTREXATE 1 0
126692271 12669227 6 C IFOSFAMIDE. IFOSFAMIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126692271 12669227 1 Osteosarcoma
126692271 12669227 3 Osteosarcoma
126692271 12669227 4 Osteosarcoma
126692271 12669227 5 Osteosarcoma
126692271 12669227 6 Osteosarcoma

Outcome of event

Event ID CASEID OUTC COD
126692271 12669227 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126692271 12669227 Haematuria
126692271 12669227 Nephrotic syndrome
126692271 12669227 Off label use
126692271 12669227 Proteinuria
126692271 12669227 Thrombotic microangiopathy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found